Please use this identifier to cite or link to this item:
Title: Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension
Authors: Glidden, David V
Amico, K Rivet
Liu, Albert Y
Hosek, Sybil G
Anderson, Peter L
Buchbinder, Susan P
McMahan, Vanessa
Mayer, Kenneth H
David, Burns
Schechter, Mauro
Grinsztejn, Beatriz
Guanira, Juan
Grant, Robert M
Affilliation: University of California, San Francisco, USA.
University of Michigan. Ann Arbor, USA.
Bridge HIV, San Francisco Department of Public Health. California, USA.
John Stroger Hospital of Cook County. Chicago, Illinois, USA.
University of Colorado. Denver, Aurora, USA.
Bridge HIV, San Francisco Department of Public Health. California, USA.
University of Washington. Seattle,USA.
Fenway Health and Beth Israel Deaconess Medical Center. Boston, Massachusetts, USA.
National Institute of Allergy and Infectious Diseases. Rockville, Maryland, USA.
Universidade Federal do Rio de Janeiro. Hospital Escola São Francisco de Assis. Projeto Praça Onze. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Investigaciones Médicas en Salud. Lima, Peru.
Gladstone Institute of Virology and San Francisco AIDS Foundation. California, USA.
Abstract: Blinded clinical trials have reported a modest and transient "start-up syndrome" with initiation of tenofovir-based pre-exposure prophylaxis (PrEP). We evaluate this phenomenon and its effect on adherence in an open-label PrEP study.
keywords: HIV prevention
Pre-exposure prophylaxis
Issue Date: 2016
Citation: GLIDDEN, D. V. et al. Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension. Clinical Infectious Diseases, v. 62, n. 9, p. 1172–1177, 2016
DOI: 10.1093/cid/ciw022
ISSN: 1058-4838
Copyright: restricted access
Appears in Collections:INI - Artigos de Periódicos

FacebookTwitterDeliciousLinkedInGoogle BookmarksBibTex Format mendeley Endnote DiggMySpace

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.